Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
| ▸ | SLC6A12 | P48065 | 3/20 | 0.36 |
| ▸ | SLC6A11 | P48066 | 3/20 | 0.36 |
| ▸ | SLC6A13 | Q9NSD5 | 3/20 | 0.36 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.33 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.33 |
| ▸ | AKR1C2 | P52895 | 1/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.33 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.30 |
| ▸ | PTGFR | P43088 | 1/20 | 0.30 |
| ▸ | PTGER2 | P43116 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18853791 | 0.89 | ALOX5 (0.38) | CA1CA2CA4SLC6A12SLC6A11 | |
| SCHEMBL8674597 | 0.88 | ALOX5 (0.44) | ALOX5TBXA2RPTGFRPTGER2 | |
| SCHEMBL1054958 | 0.88 | ALOX5 (0.44) | ALOX5TBXA2RPTGFRPTGER2 | |
| SCHEMBL18853790 | 0.88 | ALOX5 (0.44) | ALOX5TBXA2RPTGFRPTGER2 | |
| SCHEMBL8672151 | 0.88 | ALOX5 (0.44) | ALOX5TBXA2RPTGFRPTGER2 | |
| SCHEMBL670583 | 0.88 | ALOX5 (0.44) | ALOX5TBXA2RPTGFRPTGER2 | |
| SCHEMBL8676301 | 0.88 | ALOX5 (0.44) | ALOX5TBXA2RPTGFRPTGER2 | |
| SCHEMBL8673306 | 0.88 | ALOX5 (0.44) | ALOX5TBXA2RPTGFRPTGER2 | |
| SCHEMBL8676435 | 0.88 | ALOX5 (0.44) | ALOX5TBXA2RPTGFRPTGER2 | |
| SCHEMBL22002778 | 0.86 | ALOX5 (0.46) | ALOX5TBXA2RPTGFRPTGER2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3901129-A1 | METHOD FOR SYNTHESISING NOVEL 3-HYDROXY-CYCLOPENTYL ACETIC ACID DERIVATIVE COMPOUNDS | L'OREAL (FR) | 2021-10-27 | — | — | EP | disclosed |
| US-10995051-B2 | Method for synthesizing novel compounds derived from 3-hydroxy-cylopentyl acetic acid | L'OREAL (FR) | 2021-05-04 | — | — | US | disclosed |
| US-10654788-B2 | Method for synthesizing novel compounds derived from 3-hydroxy-cyclopentyl acetic acid | L'OREAL (FR) | 2020-05-19 | — | — | US | disclosed |
| US-20200131108-A1 | METHOD FOR SYNTHESIZING NOVEL COMPOUNDS DERIVED FROM 3-HYDROXY-CYLOPENTYL ACETIC ACID | L'OREAL (FR) | 2020-04-30 | — | — | US | disclosed |
| US-20180057440-A1 | METHOD FOR SYNTHESIZING NOVEL COMPOUNDS DERIVED FROM 3-HYDROXY-CYCLOPENTYL ACETIC ACID | L'OREAL (FR) | 2018-03-01 | — | — | US | disclosed |
| US-20180057440-A1 | METHOD FOR SYNTHESIZING NOVEL COMPOUNDS DERIVED FROM 3-HYDROXY-CYCLOPENTYL ACETIC ACID | L'OREAL (FR) | 2018-03-01 | — | — | US | disclosed |
| WO-2016146588-A1 | METHOD FOR SYNTHESIZING NOVEL COMPOUNDS DERIVED FROM 3-HYDROXY-CYCLOPENTYL ACETIC ACID | L'OREAL (FR) | 2016-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10654788-B2 | Method for synthesizing novel compounds derived from 3-hydroxy-cyclopentyl acetic acid | HSD17B12, FASN, AKR1C3 | CA1 376/4885CA2 1267/4885CA4 802/4885 |
| US-20180057440-A1 | METHOD FOR SYNTHESIZING NOVEL COMPOUNDS DERIVED FROM 3-HYDROXY-CYCLOPENTYL ACETIC ACID | HSD17B12, FASN, AKR1C3 | CA1 376/4885CA2 1267/4885CA4 802/4885 |
| US-10995051-B2 | Method for synthesizing novel compounds derived from 3-hydroxy-cylopentyl acetic acid | CYP8B1, HAAO, HSD17B12 | CA1 446/4885CA2 2729/4885CA4 1457/4885 |
| US-20200131108-A1 | METHOD FOR SYNTHESIZING NOVEL COMPOUNDS DERIVED FROM 3-HYDROXY-CYLOPENTYL ACETIC ACID | CYP8B1, HAAO, HSD17B12 | CA1 446/4885CA2 2729/4885CA4 1457/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.